Lista de obras -

2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism

artículo científico publicado en 2014

A strategy combining imaging and laboratory biomarkers in comparison with a simplified clinical score for risk stratification of patients with acute pulmonary embolism.

artículo científico publicado en 2011

Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity

artículo científico publicado en 2008

Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model

artículo científico publicado en 2016

Age-adjusted high-sensitivity troponin T cut-off value for risk stratification of pulmonary embolism.

artículo científico publicado en 2015

Always think of the right ventricle, even in "low-risk" pulmonary embolism

artículo científico publicado en 2017

Atrial fibrillation is frequent but does not affect risk stratification in pulmonary embolism

scientific article published on 11 October 2019

BMI-independent inverse relationship of plasma leptin levels with outcome in patients with acute pulmonary embolism ⬇️

artículo científico publicado el 20 de marzo de 2012

Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018

artículo científico publicado en 2018

Chronic thromboembolic pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016

artículo científico publicado en 2016

Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk.

artículo científico publicado en 2013

Corrigendum to:2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

artículo científico publicado en 2015

Corrigendum to:2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism:

artículo científico publicado en 2015

Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study.

artículo científico publicado en 2017

Defining right ventricular dysfunction by the use of echocardiography in normotensive patients with pulmonary embolism

artículo científico publicado en 2020

Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism

artículo científico publicado en 2015

Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis

artículo científico publicado en 2018

Effectiveness of prognosticating pulmonary embolism using the ESC algorithm and the Bova score

artículo científico publicado en 2016

Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism.

artículo científico publicado en 2010

External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

artículo científico publicado en 2014

Follow-up after acute pulmonary embolism. A prospective non-interventional multi-center cohort study (FOCUS)

artículo científico publicado en 2015

From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension

artículo científico publicado en 2017

Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.

artículo científico publicado en 2008

Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension

artículo científico publicado en 2008

Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism.

artículo científico publicado en 2006

Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.

artículo científico publicado en 2016

Identification of intermediate-risk patients with acute symptomatic pulmonary embolism.

artículo científico publicado en 2014

Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism

artículo científico publicado en 2017

Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials.

artículo científico publicado en 2018

Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?

artículo científico publicado en 2016

Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study

artículo científico publicado en 2016

Leptin signalling and leptin-mediated activation of human platelets: importance of JAK2 and the phospholipases Cgamma2 and A2

artículo científico publicado en 2007

Long-term clinical course of acute pulmonary embolism ⬇️

artículo científico publicado el 20 de junio de 2013

Management of Pulmonary Embolism: An Update.

artículo científico publicado en 2016

Medicinal treatment of tricuspid valve regurgitation

artículo científico publicado en 2017

Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH

artículo científico publicado en 2020

Mortality Risk Assessment and the Role of Thrombolysis in Pulmonary Embolism ⬇️

artículo científico publicado el 12 de agosto de 2010

Mortality risk assessment and the role of thrombolysis in pulmonary embolism.

artículo científico

Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test.

artículo científico publicado en 2011

Outcome of patients with different clinical presentations of high-risk pulmonary embolism

artículo científico publicado en 2021

Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry.

artículo científico publicado en 2016

Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism

artículo científico publicado en 2015

Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review

artículo científico publicado en 2015

Prediction and prognostic importance of in-hospital major bleeding in a real-world cohort of patients with pulmonary embolism

scientific article published on 16 March 2019

Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment.

artículo científico publicado en 2016

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study

artículo científico publicado en 2018

Pulmonary embolism hotline 2012. Recent and expected trials ⬇️

artículo científico publicado el 22 de enero de 2013

Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

artículo científico publicado en 2017

Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research.

artículo científico publicado en 2016

Quality of life and functional limitations after pulmonary embolism and its prognostic relevance

scientific article published on 13 August 2019

Response

artículo científico publicado en 2013

Risk stratification of acute pulmonary embolism based on clinical parameters, H-FABP and multidetector CT

scientific article published on 19 April 2018

Risk stratification of normotensive pulmonary embolism based on the sPESI - Does it work for all patients?

artículo científico publicado en 2015

Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin.

artículo científico publicado en 2015

Sex-specific differences in pulmonary embolism

scientific article published on 23 April 2019

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis.

artículo científico publicado en 2014

Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014.

artículo científico publicado en 2016

Temporal trends in management and outcome of pulmonary embolism: a single-centre experience

scientific article published on 07 May 2019

Tenecteplase can be given to patients with intermediate-risk pulmonary embolism--but should it?

artículo científico publicado en 2009

The Prognostic Value of Renal Function in Acute Pulmonary Embolism-A Multi-Centre Cohort Study

scientific article published on 31 December 2018

The post-PE syndrome: a new concept for chronic complications of pulmonary embolism.

artículo científico publicado en 2014

Thrombolysis for hemodynamically stable patients with pulmonary embolism: still searching for the intermediate-risk group

artículo científico publicado en 2009

Thrombolysis for pulmonary embolism: Past, present and future.

artículo científico publicado en 2010

Thrombolytic therapy for submassive pulmonary embolism.

artículo científico publicado en 2012

Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism

artículo científico publicado en 2014

Validation of a Model for Identification of Patients at Intermediate to High Risk for Complications Associated With Acute Symptomatic Pulmonary Embolism.

artículo científico publicado en 2015

Validation of a fast prognostic score for risk stratification of normotensive patients with acute pulmonary embolism

artículo científico publicado en 2020

Wytyczne ESC dotyczące rozpoznawania i postępowania w ostrej zatorowości płucnej w 2014 roku

artículo científico publicado en 2014

[Chronic thromboembolic pulmonary hypertension--a position paper]

artículo científico publicado en 2014

[Chronic thromboembolic pulmonary hypertension--a position paper]

[Pulmonary embolism: update 2013]

scientific article published on 24 July 2013

Lista de obras de

2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism

A strategy combining imaging and laboratory biomarkers in comparison with a simplified clinical score for risk stratification of patients with acute pulmonary embolism.

Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity

Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model

Age-adjusted high-sensitivity troponin T cut-off value for risk stratification of pulmonary embolism.

Always think of the right ventricle, even in "low-risk" pulmonary embolism

Atrial fibrillation is frequent but does not affect risk stratification in pulmonary embolism

BMI-independent inverse relationship of plasma leptin levels with outcome in patients with acute pulmonary embolism ⬇️

Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018

Chronic thromboembolic pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016

Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk.

Corrigendum to:2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

Corrigendum to:2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism:

Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study.

Defining right ventricular dysfunction by the use of echocardiography in normotensive patients with pulmonary embolism

Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism

Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis

Effectiveness of prognosticating pulmonary embolism using the ESC algorithm and the Bova score

Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism.

External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

Follow-up after acute pulmonary embolism. A prospective non-interventional multi-center cohort study (FOCUS)

From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension

Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.

Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension

Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism.

Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.

Identification of intermediate-risk patients with acute symptomatic pulmonary embolism.

Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism

Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials.

Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?

Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study

Leptin signalling and leptin-mediated activation of human platelets: importance of JAK2 and the phospholipases Cgamma2 and A2

Long-term clinical course of acute pulmonary embolism ⬇️

Management of Pulmonary Embolism: An Update.

Medicinal treatment of tricuspid valve regurgitation

Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH

Mortality Risk Assessment and the Role of Thrombolysis in Pulmonary Embolism ⬇️

Mortality risk assessment and the role of thrombolysis in pulmonary embolism.

Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test.

Outcome of patients with different clinical presentations of high-risk pulmonary embolism

Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry.

Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism

Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review

Prediction and prognostic importance of in-hospital major bleeding in a real-world cohort of patients with pulmonary embolism

Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment.

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study

Pulmonary embolism hotline 2012. Recent and expected trials ⬇️

Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research.

Quality of life and functional limitations after pulmonary embolism and its prognostic relevance

Response

Risk stratification of acute pulmonary embolism based on clinical parameters, H-FABP and multidetector CT

Risk stratification of normotensive pulmonary embolism based on the sPESI - Does it work for all patients?

Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin.

Sex-specific differences in pulmonary embolism

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis.

Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014.

Temporal trends in management and outcome of pulmonary embolism: a single-centre experience

Tenecteplase can be given to patients with intermediate-risk pulmonary embolism--but should it?

The Prognostic Value of Renal Function in Acute Pulmonary Embolism-A Multi-Centre Cohort Study

The post-PE syndrome: a new concept for chronic complications of pulmonary embolism.

Thrombolysis for hemodynamically stable patients with pulmonary embolism: still searching for the intermediate-risk group

Thrombolysis for pulmonary embolism: Past, present and future.

Thrombolytic therapy for submassive pulmonary embolism.

Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism

Validation of a Model for Identification of Patients at Intermediate to High Risk for Complications Associated With Acute Symptomatic Pulmonary Embolism.

Validation of a fast prognostic score for risk stratification of normotensive patients with acute pulmonary embolism

Wytyczne ESC dotyczące rozpoznawania i postępowania w ostrej zatorowości płucnej w 2014 roku

[Chronic thromboembolic pulmonary hypertension--a position paper]

[Chronic thromboembolic pulmonary hypertension--a position paper]

[Pulmonary embolism: update 2013]